Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Mahmoud Aljurf et al.|Blood|2017Cited by 296
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic SyndromesChristine Duncan, Mohamed L. Sorror, Navneet S. Majhail et al.|Biology of Blood and Marrow Transplantation|2014Cited by 64